Cantel Medical Corp/ US1380981084 /
| - - | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| -USD | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | 3.4 bill.USD | 0.13% | 251.16 |
Assets
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 52.7180 | 62.5410 | 74.6040 | 88.3380 | 111.4170 | ||||||
| Intangible Assets | 82.9520 | 85.8360 | 111.7190 | 124.5120 | 137.3610 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 372.2360 | 395.6700 | 471.7900 | 529.0020 | 625.4650 | ||||||
| Inventories | 59.7370 | 72.0780 | 91.4860 | 98.7240 | 107.5920 | ||||||
| Accounts Receivable | 62.2250 | 69.8050 | 93.3320 | 110.6560 | 118.6420 | ||||||
| Cash and Cash Equivalents | 31.7810 | 31.7200 | 28.3670 | 36.5840 | 94.0970 | ||||||
| Current Assets | 163.9090 | 188.3610 | 222.7420 | 257.3710 | 338.2430 | ||||||
| Total Assets | 536.1450 | 584.0310 | 694.5320 | 786.3730 | 963.7080 | ||||||
Liabilities
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 19.5290 | 16.1840 | 26.2630 | 27.4690 | 34.2580 | ||||||
| Long-term debt | 80.5000 | 78.5000 | 116 | 126 | 187.3020 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 18.7000 | 26.2000 | 27.7000 | 27.9000 | 30.4000 | ||||||
| Liabilities | 170.8990 | 177.3980 | 240.1620 | 262.4410 | 354.8410 | ||||||
| Share Capital | 4.5640 | 4.5910 | 4.6080 | 4.6190 | 4.6240 | ||||||
| Total Equity | 365.2460 | 406.6330 | 454.3700 | 523.9320 | 608.8670 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 536.1450 | 584.0310 | 694.5320 | 786.3730 | 963.7080 | ||||||
Income Statement
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 488.7490 | 565.0040 | 664.7550 | 770.1570 | 871.9220 | ||||||
| Depreciation (total) | 18.8860 | 23.9570 | 25.0840 | 33.4520 | 34.8300 | ||||||
| Operating Result | 70.9280 | 80.7610 | 97.2510 | 110.4100 | 121.6640 | ||||||
| Interest Income | -2.3170 | -2.3640 | -3.3200 | -4.3030 | -5.2890 | ||||||
| Income Before Taxes | 68.6110 | 76.1910 | 93.9310 | 106.2330 | 117.5130 | ||||||
| Income Taxes | 25.3460 | 28.2380 | 33.9780 | 34.8550 | 26.4720 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 43.2650 | 47.9530 | 59.9530 | 71.3780 | 91.0410 | ||||||
Per Share
Cash Flow
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 64.2720 | 59.0700 | 80.2680 | 108.1930 | 125.9120 | ||||||
| Cash Flow from Investing Activities | -47.4320 | -52.2940 | -112.9820 | -97.0620 | -125.1860 | ||||||
| Cash Flow from Financing | -18.9490 | -6.1050 | 29.9420 | -2.7510 | 57.1370 | ||||||
| Decrease / Increase in Cash | -2.2950 | -.0610 | -3.3530 | 8.2170 | 57.5130 | ||||||
| Employees | 1,534 | 1,680 | 2,000 | 2,337 | 2,693 | ||||||
